Early Phase Clinical Site

BRING MODERN MEDICINE TO EVERYDAY LIFE

bioresearch group

BioResearch Group is a dedicated clinical site conducting early phase clinical trials as well as bioequivalence and bioavailability studies for biotech, pharma and CRO companies.

Our high quality service covers a wide range of medical, laboratory and pharmaceutical procedures, as well as administration and management of the study performed. We provide full clinical trial services from protocol design, study start-up, conduct and final study report preparation. Our team is a challenge-oriented, highly engaged, motivated and specialised in phase 1 clinical trials.

BioResearch Group has a dedicated space within the hospital premises exclusively for conducting early phase trials. This includes clinics for consultants to see patients, sample collection room, data entry room or drug storage.

Our high quality of services is confirmed by GCLP accreditation by Qualogy Ltd (No 06019).

Read more...

bioresearch group - Contact

CLINICAL TRIALS OFFICE

Sokołowska 9/U-2 St
Warsaw, 01-142
Poland

CLINICAL SITE

Mokra 7 St
Kajetany, 05-830 Nadarzyn
Poland

CONSULTANT

Telephone: +48 22 112 19 51, 52
Fax: +48 22 112 19 54
E-mail: info@bioresearch.pl

Contact details...

News

Dr Jarosław Długołęcki

We are pleased to welcome a new member of the BRG medical expert team. Mr Jarosław Długołęcki, (M.D.) - doctor with extensive knowledge and 16-years’ experience in clinical studies at the international level.

Read more …

Badania kliniczne faz wczesnych szczepionek – wyzwania w obliczu nowych zagrożeń

Szczepienia ochronne niezaprzeczalnie należą do jednych z najbardziej przełomowych odkryć nowoczesnej medycyny.

Read more …

Publication in the Biotechnology magazine

We invite you to read our publication in the Biotechnology magazine - the largest industry portal in Poland, the latest information from the sectors: biotechnology, cosmetology, pharmacy and technologies.

Read more …

Promising antidiabetic drug

We have started an interesting study with a promising antidiabetic drug. The drug is designed in the form of prolonged-action tablets, which action leads to increased insulin secretion.

 

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2020 © Bio Research Group. All rights reserved.

 

scroll to top ▲